Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: A 17-Year Single-Center Experience

Puntos clave

• Allogeneic transplantation shows promising clinical outcomes in acute lymphoblastic leukemia patients after 17 years.
• The study highlights significant findings regarding graft-versus-host disease management and patient recovery.
• Data collected over a 17-year single-center experience illustrates treatment effectiveness and patient survival rates.
• These findings support the use of allogeneic transplantation, indicating potential for improved patient outcomes.